Revance Therapeutics Inc (DELISTED) (RVNC:DL)

3.65 0.00 (0.00%) USD  |  NASDAQ  |  Feb 06, 16:00
More

Revance Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for RVNC:DL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
BioAge Labs, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
Cellectar Biosciences, Inc. Upgrade
Hepion Pharmaceuticals, Inc. Upgrade